Bayer Aktiengesellschaft (BAYRY)

USD 4.92

(-2.19%)

Inventory Summary of Bayer Aktiengesellschaft

  • Bayer Aktiengesellschaft's latest annual inventory in 2023 was 13.94 Billion EUR , up 2.59% from previous year.
  • Bayer Aktiengesellschaft's latest quarterly inventory in 2024 Q2 was 13.08 Billion EUR , down -2.6% from previous quarter.
  • Bayer Aktiengesellschaft reported annual inventory of 13.59 Billion EUR in 2022, up 20.63% from previous year.
  • Bayer Aktiengesellschaft reported annual inventory of 11.27 Billion EUR in 2021, up 2.88% from previous year.
  • Bayer Aktiengesellschaft reported quarterly inventory of 13.08 Billion EUR for 2024 Q2, down -2.6% from previous quarter.
  • Bayer Aktiengesellschaft reported quarterly inventory of 13.94 Billion EUR for 2023 Q4, down -0.06% from previous quarter.

Annual Inventory Chart of Bayer Aktiengesellschaft (2023 - 1998)

Historical Annual Inventory of Bayer Aktiengesellschaft (2023 - 1998)

Year Inventory Inventory Growth
2023 13.94 Billion EUR 2.59%
2022 13.59 Billion EUR 20.63%
2021 11.27 Billion EUR 2.88%
2020 10.95 Billion EUR 1.76%
2019 10.76 Billion EUR 9.5%
2018 9.83 Billion EUR 50.39%
2017 6.53 Billion EUR -22.06%
2016 8.38 Billion EUR -1.76%
2015 8.53 Billion EUR 1.82%
2014 8.38 Billion EUR 17.85%
2013 7.11 Billion EUR 2.11%
2012 6.96 Billion EUR 9.41%
2011 6.36 Billion EUR 4.33%
2010 6.1 Billion EUR 0.21%
2009 6.09 Billion EUR -8.83%
2008 6.68 Billion EUR 7.46%
2007 6.21 Billion EUR 1.04%
2006 6.15 Billion EUR 11.88%
2005 5.49 Billion EUR -11.44%
2004 6.21 Billion EUR 5.71%
2003 5.87 Billion EUR -7.45%
2002 6.34 Billion EUR 8.93%
2001 5.82 Billion EUR -4.65%
2000 6.11 Billion EUR 22.43%
1999 4.99 Billion EUR -13.65%
1998 5.78 Billion EUR 0.0%

Peer Inventory Comparison of Bayer Aktiengesellschaft

Name Inventory Inventory Difference
AstraZeneca PLC 5.41 Billion USD -157.499%
Bristol-Myers Squibb Company PFD CONV 2 2.66 Billion USD -423.929%
CSPC Pharmaceutical Group Limited 442.43 Million USD -3052.353%
Clarus Therapeutics Holdings, Inc. 14.21 Million USD -98021.57%
Novartis AG 5.91 Billion USD -135.87%
PT Kalbe Farma Tbk. 451.27 Million USD -2990.543%